Female Hormone Health, PCOS, Endometriosis, Fertility & Breast Cancer | Dr. Thaïs Aliabadi

Key Takeaways

PCOS and endometriosis are common but frequently undiagnosed conditions causing infertility and chronic pain in women.
Early screening, including AMH tests and pelvic ultrasounds, is crucial for timely diagnosis and intervention in young women.
Women's health issues are often dismissed by medical professionals, highlighting the need for patient advocacy and improved education.
PCOS management requires addressing insulin resistance, inflammation, and hormonal imbalances through lifestyle, supplements, and medication.
Endometriosis, an autoimmune-linked inflammatory condition, requires surgical excision and hormonal suppression for effective treatment.
Comprehensive well-woman exams should include fertility assessments and personalized breast cancer risk screening.

Endometriosis and Polycystic Ovary Syndrome (PCOS) are leading causes of female infertility, often dismissed as normal or psychological symptoms.
Early diagnosis and treatment could prevent later fertility issues; a 14-year-old patient with endometriosis presented an egg count of a 40-year-old.
Early screening for girls with severe pain or missed school should include AMH tests to assess egg count, as traditional age-based fertility data is insufficient.

Polycystic Ovary Syndrome (PCOS) affects 15% of reproductive-aged women globally, with 70-90% undiagnosed or inadequately treated.
Diagnosis requires two of three criteria: high androgen symptoms (acne, hair thinning), irregular ovulation (periods over 35 days apart), or PCOS-appearing ovaries/high AMH.
Four distinct PCOS phenotypes exist, complicating diagnosis; symptoms like persistent acne (over age 25) and hair thinning are key indicators.

GLP-1 medications and metformin effectively address insulin resistance, weight management, and ovulation issues in PCOS patients.
GLP-1s, used since 2014 for PCOS, can improve motivation, self-esteem, and reduce cravings, including for alcohol.
Berberine offers short-term insulin sensitivity benefits, but long-term chronic use for PCOS is cautioned against.

Insulin resistance affects up to 80% of PCOS patients, including lean individuals, hindering cells from efficiently absorbing glucose.
Excessive androgens, exacerbated by high insulin, worsen symptoms such as acne, hair loss, and irregular periods.
Visceral fat, even in lean individuals, releases inflammatory cytokines that intensify insulin resistance and androgen production, creating a feedback loop.

PCOS can cause falsely high AMH and egg counts due to immature follicles, but these eggs often have lower quality and reduced conception chances.
Freezing eggs by age 28-30 is advised for PCOS patients, potentially aiming for 20 or more eggs due to quality variability.
50% of U.S. counties lack an OB/GYN, highlighting a systemic barrier to care and the potential for technology like AI to bridge diagnostic gaps.

PCOS is often misdiagnosed due to common misconceptions, such as normal testosterone levels or regular periods, necessitating understanding of all four phenotypes.
Short doctor-patient times and inadequate training lead to delays; many patients receive only birth control, overlooking underlying issues like insulin resistance.
Patients must become advocates, researching symptoms and requesting specific tests like AMH and pelvic ultrasounds.

Endometriosis is common, co-occurring in over 50% of PCOS patients, with a U.S. diagnostic delay averaging 9-11 years.
Severe, life-disrupting menstrual pain, painful intercourse, chronic bloating, and painful bowel movements are not normal and indicate endometriosis.
Undiagnosed endometriosis leads to chronic pain, infertility, psychological distress, and can result in job loss, highlighting systemic healthcare issues.

Endometriosis significantly increases infertility risk due to inflammation, scarred fallopian tubes, diminished egg quality, and a hostile uterine environment.
Ovarian endometriomas, or 'chocolate cysts,' can drastically reduce egg count and quality, emphasizing the need for early screening and egg count assessment.
Adenomyosis, where uterine lining tissue grows into the uterine wall, causes heavy/painful periods and recurrent miscarriages, detectable by experienced practitioners via pelvic ultrasound.

Laparoscopic resection is the gold standard surgical treatment for endometriosis lesions, with burning being less effective due to nerve regrowth.
Progesterone birth control, IUDs, or GNRH antagonists are used to suppress symptoms and estrogen, with GNRH antagonists limited to two years.
Endometriosis stage does not correlate with pain severity; certain types, like stromal endometriosis, are resistant to progesterone and require aggressive treatment.

Women's health concerns are often dismissed or misdiagnosed; 99% of women's reported issues are legitimate, not psychosomatic.
Systemic issues include short doctor appointment times and inadequate training, leading to misdiagnoses and unnecessary procedures for conditions like endometriosis.
A proposed solution is separating obstetrics and gynecology residencies to allow gynecologists to specialize in complex conditions and minimally invasive surgeries.

Fertility assessment requires a multi-bucket approach: checking female factors (hormones, egg count), male factors (semen analysis), tubal/anatomical issues, and autoimmune conditions.
For breast cancer, the Tyrer-Cuzick Risk Assessment Tool helps identify women with a 20% or more lifetime risk, who may need imaging like mammograms, ultrasounds, and MRIs starting at age 30.
85% of breast cancer occurs without family history; calculating lifetime risk and advocating for personalized screening are crucial for early detection.

Cognitive impairment ('brain fog') during menopause is common due to estrogen drops, often alleviated by hormone replacement therapy.
Premenstrual Dysphoric Disorder (PMDD), a severe PMS form, involves the brain's extreme reaction to hormonal changes and can be treated with SSRIs or specific birth control.
Hair loss in perimenopause is typically due to estrogen decline and can be managed with topical or oral minoxidil, while improving egg quality involves reducing visceral fat and inflammation.